The effects of YAP/TAZ in cardiomyocytes: a scoping review
- PMID: 40232357
- DOI: 10.1007/s11033-025-10492-5
The effects of YAP/TAZ in cardiomyocytes: a scoping review
Abstract
The Hippo signaling pathway, through its effectors' yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ), plays a pivotal role in heart development, regeneration, and repair. Despite the well-recognized role of YAP in promoting cardiomyocyte proliferation and differentiation, the underlying mechanisms require further explanation. Therefore, this scoping review was conducted to explore the underlying mechanisms of YAP and TAZ in cardiomyocyte biology. In this scoping review, 138 studies were screened using PRISMA extension for scoping reviews guidelines to examine the upstream regulators, mechanisms, and therapeutic potential of YAP/TAZ in cardiomyocytes. Articles were selected based on relevance to YAP/TAZ signaling in cardiac regeneration and focused on upstream regulators, signaling pathways, and therapeutic applications. Data were extracted using standardized forms, and thematic analysis was performed iteratively. YAP activation regulated several processes, including cardiomyocyte proliferation, differentiation, and protection against oxidative stress. Mechanotransduction factors influence YAP activity, linking the biomechanical environment to cardiac regeneration. Novel upstream regulators, such as prorenin receptors, melatonin, and ERBB2, were identified as YAP/TAZ modulators. Moreover, downstream pathways such as Wnt/β-catenin, PI3K/Akt, and TLR-mediated inflammation confer their effects on cellular proliferation, mitochondrial dynamics, and inflammation. Several therapeutic targets involving YAP that could enhance cardiac regeneration while reducing fibrosis and inflammation were identified. However, significant research gaps remain, including the underexplored role of TAZ, necessity for in vivo studies and transcriptomics to elucidate cell-specific effects, and intricate regulatory networks of YAP/TAZ.
Keywords: Cardiomyocytes; Myocardial injury; Myocardial regeneration; Transcriptional coactivator with PDZ-binding motif; Yes-associated protein.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Ethical approval: Not Applicable. Consent to participate: Not Applicable. Consent to publish: Not Applicable. Competing interests: The authors declare no competing interests.
Similar articles
-
YAP/TAZ as master regulators in liver regeneration and disease: insights into mechanisms and therapeutic targets.Mol Biol Rep. 2024 Dec 24;52(1):78. doi: 10.1007/s11033-024-10177-5. Mol Biol Rep. 2024. PMID: 39718664 Review.
-
Exploring Hippo YAP/TAZ Signaling: A Novel Avenue for Cardiovascular Disorders.Cell Biol Int. 2025 Sep;49(9):1079-1101. doi: 10.1002/cbin.70052. Epub 2025 Jul 14. Cell Biol Int. 2025. PMID: 40654305 Review.
-
Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target.Anticancer Res. 2024 Oct;44(10):4147-4153. doi: 10.21873/anticanres.17245. Anticancer Res. 2024. PMID: 39348982 Review.
-
An overview of signaling pathways regulating YAP/TAZ activity.Cell Mol Life Sci. 2021 Jan;78(2):497-512. doi: 10.1007/s00018-020-03579-8. Epub 2020 Aug 3. Cell Mol Life Sci. 2021. PMID: 32748155 Free PMC article. Review.
-
Role of Hippo-YAP/TAZ signaling pathway in organ fibrosis.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024 Sept 28;49(9):1509-1516. doi: 10.11817/j.issn.1672-7347.2024.230577. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39931781 Free PMC article. Review. Chinese, English.
Cited by
-
Substrate stiffness-dependent metabolic reprogramming of iPSC-derived cardiomyocytes on physiological PDMS polymers.Metab Eng Commun. 2025 Jul 8;21:e00266. doi: 10.1016/j.mec.2025.e00266. eCollection 2025 Dec. Metab Eng Commun. 2025. PMID: 40704293 Free PMC article.
References
-
- Meng Z, Moroishi T, Guan K-L (2016) Mechanisms of Hippo pathway regulation. Genes Dev 30:1–17. https://doi.org/10.1101/gad.274027.115 - DOI - PubMed - PMC
-
- Mia MM, Singh MK (2019) The Hippo signaling pathway in cardiac development and diseases. Front Cell Dev Biol 7. https://doi.org/10.3389/fcell.2019.00211
-
- Galan JA, Avruch J (2016) MST1/MST2 protein kinases: regulation and physiologic roles. Biochemistry 55:5507–5519. https://doi.org/10.1021/acs.biochem.6b00763 - DOI - PubMed
-
- Furth N, Aylon Y (2017) The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway. Cell Death Differ 24:1488–1501. https://doi.org/10.1038/cdd.2017.99 - DOI - PubMed - PMC
-
- Meng Z, Moroishi T, Mottier-Pavie V et al (2015) MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun 6:8357. https://doi.org/10.1038/ncomms9357 - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous